Abstract
Patients with malignant tumor are easy to be complicated with venous thrombosis, which is the second leading cause of death for patients with malignant tumor. The mechanism of tumor thrombus formation is related to tumor type, treatment, metastasis, heredity and tumor itself. Evaluating the risk of venous thrombosis in patients with cancer and providing targeted preventive anticoagulation measures for high-risk patients have important significances for improving the quality of life and prolonging the survival period of patients with cancer. Key words: Neoplasms; Thrombosis; Therapy
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
